Clinical Trials Logo
  1. Home
  2. Vancomycin
  3. NCT05257070

The Clinical Validation of a Dried Blood Spot Method for Vancomycin and Creatinine — ADVANCED  

Vancomycin Clinical Trial

Official title:
The Clinical Validation of a Dried Blood Spot Method for Vancomycin and Creatinine

Clinical Trial Summary

A widely used antibiotic is vancomycin. To ensure adequate exposure to vancomycin, drug doses are adjusted based on whole-blood concentration measurements, a practice known as therapeutic drug monitoring (TDM). The need for TDM of vancomycin is well established, as described in several national and international guidelines, for dose-optimization in order to achieve successful treatment and to prevent toxicity and reduce microbial resistance. A sampling method for TDM that has become more popular over the recent years is dried blood spotting (DBS). DBS is a design of blood sampling consisting of positioning a drop of capillary blood, preferably taken from the finger, on filter paper. Unlike venous blood sampling (the current gold standard for TDM of vancomycin), DBS seems to have advantages for the patient. The finger prick is less invasive than venipuncture. DBS also enables patients to perform one or multiple finger prick(s) themselves, with the possibility to sample at multiple time points. Due to the fact that vancomycin is nephrotoxic, it would be very efficient and convenient to measure creatinine in the same dried blood spot as the vancomycin. This study is a clinical validation study to validate the DBS assay for vancomycin.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05257070
Study type Observational
Source Erasmus Medical Center
Contact Brenda de Winter, PharmD
Phone 010-7033202
Email b.dewinter@erasmusmc.nl
Status Recruiting
Phase
Start date March 21, 2022
Completion date February 1, 2024
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03221023 - Intrawound Vancomycin Prophylaxis for Neural Stimulator Phase 2/Phase 3
Recruiting NCT03456544 - Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China
Not yet recruiting NCT05964114 - First Time Right of Vancomycin N/A
Completed NCT02951702 - Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics Phase 4
Completed NCT05535075 - Model-informed Precision Dosing of Vancomycin in Adults Phase 4
Active, not recruiting NCT04911270 - Clinical Decision Support Tool for Vancomycin Dosing in Children N/A
Recruiting NCT05823116 - Continuous vs. Intermittent Infusion Vancomycin Phase 4
Recruiting NCT02456974 - Antibiotic Dosing in Pediatric Intensive Care
Enrolling by invitation NCT03585426 - Vancomycin in the Target Site Treatment of Intracranial Infection Phase 4
Completed NCT04756895 - Vancomycin Dose Adjustments Comparing Trough Levels to The AUC/MIC Method Using a Bayesian Approach in a Hospitalized Adult Population N/A
Suspended NCT02590523 - Intracameral Antibiotic Safety Study Phase 3
Completed NCT03806543 - The Influencing Factors of Vancomycin Trough Level and the Rate Achieving the Target Trough Level
Recruiting NCT04758442 - Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncology N/A
Completed NCT04042233 - Intraosseous Vancomycin in Primary Total Hip Arthroplasty - Designing a Protocol Phase 4
Active, not recruiting NCT04666948 - Precision Dosing of Vancomycin in Critically Ill Children Phase 4
Recruiting NCT02667418 - Optimal Treatment for Recurrent Clostridium Difficile Phase 4
Recruiting NCT06069206 - Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes N/A
Completed NCT03453684 - Pharmacokinetics of Preoperative Vancomycin Phase 4